DDR Deficiency and Replication Stress as Therapeutic Targets for Pancreatic Cancer - 2023

Watch a scientific symposium presentation exploring DDR deficiency and replication stress as potential therapeutic targets for pancreatic cancer, delivered by Dr. David Chang from the University of Glasgow at the 2023 Dana-Farber Cancer Institute Center for BRCA and Related Genes Scientific Symposium. Delve into cutting-edge research examining how DNA damage response (DDR) deficiency and replication stress mechanisms can be leveraged for developing targeted treatments in pancreatic cancer therapy. Learn about the latest developments in BRCA-related cancer research and their implications for improving pancreatic cancer treatment outcomes during this 45-minute expert presentation.